2011

1. First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)

   Critical Reviews in Oncology/Hematology, Vol. 77, Núm. 1, pp. 78-84

2. Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

   Clinical and Translational Oncology, Vol. 13, Núm. 3, pp. 179-184